Bacteria News and Research

RSS

TREM-1 gene disrupts inflammatory process implicated in liver cancer

Researchers at the Georgia Health Sciences University Cancer Center have identified a gene that disrupts the inflammatory process implicated in liver cancer.

23 Aug 2012

RNA switches can better equip and regulate viruses for many therapeutic applications

Numerous viruses are used in the service of science today. They serve as gene taxis to transfer therapeutic genes into body cells or as therapeutic viruses targeted to infect and destroy cancer cells. For such applications, the viruses are often equipped with additional genes, such as for immune mediators or for proteins inducing programmed cell death. However, these gene products can harm the body if they are released at the wrong moment or at excessive levels.

22 Aug 2012

Study identifies certain small molecule chemicals that can disrupt quorum sensing in A. baumanni

Acinetobacter baumanni, a pathogenic bacterium that is a poster child of deadly hospital acquired infections, is one tough customer.

22 Aug 2012

Study: Declining rates of circumcisions among infants could drive up health care costs

Johns Hopkins researchers examine the 20-year decline in male circumcision rates and assert it could raise medical costs related to sexually transmitted diseases and other health problems.

22 Aug 2012

Clinical trial to test whether fecal transplantation is effective in treating relapsing C. difficile

For patients with Clostridium difficile (C. difficile), a persistent and potentially deadly bacterial illness, severe diarrhea, abdominal pain, nausea and vomiting are an everyday event. This particularly virulent infection is prone to recurrence, even after multiple courses of expensive antibiotics, and treatment options are limited for patients who continually relapse or develop antibiotic resistance.

22 Aug 2012

Chimpanzees from African sanctuaries carry drug-resistant strains of Staph

Chimpanzees from African sanctuaries carry drug-resistant, human-associated strains of the bacteria Staphlyococcus aureus, a pathogen that the infected chimpanzees could spread to endangered wild ape populations if they were reintroduced to their natural habitat, a new study shows.

22 Aug 2012

Study analyzes association between antibiotic use and body mass starting in infancy

Treating very young infants with antibiotics may predispose them to being overweight in childhood, according to a study of more than 10,000 children by researchers at the NYU School of Medicine and the NYU Wagner School of Public Service and published in the online August 21, 2012, issue of the International Journal of Obesity.

22 Aug 2012

FDA clears Covalon’s SurgiClear antimicrobial silicone adhesive film dressing

Covalon Technologies Ltd., an advanced medical technologies company, today announced United States Food and Drug Administration ("FDA") clearance of SurgiClear antimicrobial silicone adhesive film dressing designed to cover and protect wound sites and wound closure devices, as well as secure other primary dressings to a patient's skin.

22 Aug 2012

Sore throat treatment should be individually tailored

Throat discomfort may have a variety of causes and a range of symptoms, all of which should be considered before decisions about treatment are made, report researchers.

21 Aug 2012

Declining circumcision rates in the US raise healthcare costs and disease risk

A team of disease experts and health economists at Johns Hopkins warns that steadily declining rates of U.S. infant male circumcision could add more than $4.4 billion in avoidable health care costs if rates over the next decade drop to levels now seen in Europe.

21 Aug 2012

Declining rates of circumcision in US infant males could add billions to health care costs

21 Aug 2012

Researchers reveal possible drug targets to combat anthrax

A trawl of the genome of the deadly bacterium Bacillus anthracis has revealed a clutch of targets for new drugs to combat an epidemic of anthrax or a biological weapons attack.

21 Aug 2012

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today successful results from two programs of work carried out by French partner VIVALIS (NYSE Euronext: VLS), confirming the ability of BioDiem’s Live Attenuated Influenza Virus (LAIV) to grow in VIVALIS’ proprietary EB66® cell line.

20 Aug 2012

Live bacteria in more than 90% of middle ear effusions

Live bacteria are present in more than 90% of middle ear effusions, research shows.

20 Aug 2012

Injectable controlled-release capsules against gum disease

Scientists are trying to open a new front in the battle against gum disease, the leading cause of tooth loss in adults and sometimes termed the most serious oral health problem of the 21st century. They described another treatment approach for the condition in a report here today at the 244th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

20 Aug 2012

Two Johns Hopkins scientists receive NCI grant for Provocative Questions project

Two Johns Hopkins scientists are among the first recipients of grants geared to answer "Provocative Questions" in cancer research, a new project funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). Cynthia Sears, M.D., and Peter Searson, Ph.D., will receive more than $500,000 combined in the first of five years of funding.

17 Aug 2012

Hospital records link C.diff to 2 times more deaths than federal estimates indicate

A USA TODAY investigation shows that C. diff is far more prevalent than federal reports suggest. The bacteria is linked in hospital records to more than 30,000 deaths a year in the United States -- about twice federal estimates and rivaling the 32,000 killed in traffic accidents. It strikes about a half-million Americans a year.

17 Aug 2012

Bacteria News and Research

TREM-1 gene disrupts inflammatory process implicated in liver cancer

RNA switches can better equip and regulate viruses for many therapeutic applications

Study identifies certain small molecule chemicals that can disrupt quorum sensing in A. baumanni

Study: Declining rates of circumcisions among infants could drive up health care costs

Clinical trial to test whether fecal transplantation is effective in treating relapsing C. difficile

Chimpanzees from African sanctuaries carry drug-resistant strains of Staph

Study analyzes association between antibiotic use and body mass starting in infancy

FDA clears Covalon’s SurgiClear antimicrobial silicone adhesive film dressing

Sore throat treatment should be individually tailored

Declining circumcision rates in the US raise healthcare costs and disease risk

Declining rates of circumcision in US infant males could add billions to health care costs

Researchers reveal possible drug targets to combat anthrax

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Live bacteria in more than 90% of middle ear effusions

Injectable controlled-release capsules against gum disease

Two Johns Hopkins scientists receive NCI grant for Provocative Questions project

Hospital records link C.diff to 2 times more deaths than federal estimates indicate

Vancomycin may not always be the best choice for treatment of bloodstream infections

PKS-positive E. coli may encourage development of colon cancer

Rhomboid enzymes and malaria treatment: an interview with Sinisa Urban

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo